se of 2.5% Lidocaine cream and 2.5% Prilocaine cream for analgesia pre lombar puncture of subaracnoideo blocking in programmed cesarians

Financiamento Próprio0 个研究点开始时间: 2019年3月15日最近更新: 2023年5月29日

试验速览

暂无简介。

•Female patients; over 18 years; pregnant women (above 37 weeks); physical status ASA II; to be submitted to subarachnoid anesthesia for elective cesarean surgery.

•Will not be included in the study: Patients who refuse to participate in the study; patients in labor; who are taking any sedative, opioid or sleep inducing drugs; who have a history of allergy to any drug to be used in the study; severe obesity (defined by a BMI of more than 35 kg.m2), methemoglobinemia, carriers of pathologies that cause some cognitive deficit, such as schizophrenia, oligophrenia, severe depression, etc. If this occurs, the patients will be excluded from the clinical trial, but will not suffer harm in their treatment.
•Patients who begin labor during the latency period of topical medication, who require cesarean section before completing 60 minutes after application of the patch containing the cream (anesthetic or placebo), who request their exclusion from the study, will be excluded from the study. study during their performance, who present an allergic reaction during anesthesia or who present partial or total failure of the anesthetic block.

发起方

Financiamento Próprio